MTBP inhibits migration and metastasis of hepatocellular carcinoma

Clinical & Experimental Metastasis
Qian BiTomoo Iwakuma

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide with increasing incidence. Despite curative surgical resection and advanced chemotherapy, its survival rate remains low. The presence of microvascular invasion and occult metastasis is one of the major causes for this poor outcome. MDM2 Binding Protein (MTBP) has been implicated in the suppression of cell migration and cancer metastasis. However, clinical significance of MTBP, particularly in human cancer, is poorly understood. Specifically, clinical relevance of MTBP in human HCC has never been investigated. Here we demonstrated that expression of MTBP was significantly reduced in human HCC tissues compared to adjacent non-tumor tissues. MTBP expression was negatively correlated with capsular/vascular invasion and lymph node metastasis. Overexpression of MTBP resulted in the suppression of the migratory and metastatic potential of HCC cells, while its downregulation increased the migration. Consistent with the previous report, MTBP endogenously bound to alpha-actinin 4 (ACTN4) and suppressed ACTN4-mediated cell migration in multiple HCC cell lines. However, MTBP also inhibited migratory potential of PLC/PRF/5 HCC cells whose migration was not altered by...Continue Reading

References

Apr 29, 1998·The Journal of Cell Biology·K HondaS Hirohashi
Jul 25, 2000·The Journal of Biological Chemistry·M T BoydD S Haines
Jan 6, 2005·Molecular and Cellular Biology·Mark BradyMark T Boyd
Jan 12, 2007·Virchows Archiv : an International Journal of Pathology·Katharina SchmidFritz Wrba
Jan 19, 2007·World Journal of Gastroenterology : WJG·Kiminori UkaKazuaki Chayama
Mar 16, 2007·Biochemical and Biophysical Research Communications·Juan GaoDaiming Fan
Oct 2, 2007·Oncogene·T IwakumaG Lozano
Mar 26, 2008·Laboratory Investigation; a Journal of Technical Methods and Pathology·Maria V BarbolinaM Sharon Stack
May 19, 2009·Trends in Biochemical Sciences·Alyssa Bouska, Christine M Eischen
Dec 9, 2009·Urology·Takahiro KoizumiHiroomi Kanayama
Jan 29, 2011·Cell Death and Differentiation·N AgarwalT Iwakuma
Feb 1, 2011·The International Journal of Biological Markers·Xiuping ChenYitao Wang
Mar 15, 2011·Surgical Oncology·Terence C Chua, David L Morris
Feb 23, 2012·Lancet·Alejandro FornerJordi Bruix
Feb 8, 2013·The American Journal of Surgical Pathology·Jun AkibaHirohisa Yano
Aug 21, 2013·Clinics and Research in Hepatology and Gastroenterology·Clément GuillotIsabelle Chemin
May 3, 2014·Cancer Research·Brian C GriebChristine M Eischen
May 29, 2014·Molecular Cancer Research : MCR·Brian C GriebChristine M Eischen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.